Course Overview
RheumNow Live 2025 is a comprehensive, expert-led educational program designed to deliver the latest clinical updates and practical insights in rheumatology. The course focuses on recent therapeutic advancements, evolving treatment strategies, and real-world challenges in managing complex rheumatic diseases.
Key areas of emphasis include the integration of emerging biologic therapies, as well as targeted treatments such as JAK and TYK2 inhibitors, into routine clinical practice. The program also highlights advancements in diagnostic imaging and evidence-based approaches to disease monitoring and long-term patient care.
Learning Objectives
Participants will be able to:
-
Evaluate the efficacy, safety, and appropriate clinical use of new biologic therapies, JAK inhibitors, and TYK2 inhibitors across a range of rheumatic conditions.
-
Apply advanced imaging techniques for accurate diagnosis and ongoing monitoring of diseases such as spondyloarthritis and vasculitis.
-
Develop comprehensive, patient-centered management strategies for rheumatoid arthritis, including the management of disease flares, multimorbidity, and age-related considerations.
-
Analyze current evidence, including head-to-head clinical studies, to inform optimal biologic selection and treatment strategies in psoriatic disease.
-
Implement updated clinical guidelines for complex conditions such as systemic lupus erythematosus, including modern steroid protocols and targeted therapeutic approaches.
Target Audience
This course is designed for:
-
Rheumatologists
-
Clinical immunologists
-
Healthcare professionals involved in the management of autoimmune and inflammatory diseases
It is particularly valuable for clinicians seeking to stay current with advancements in biologic therapies, targeted treatments, and multidisciplinary care strategies.
Program Topics
The course includes a broad range of focused sessions covering:
Therapeutic Advances and Clinical Practice
-
Advances in the treatment of spondyloarthritis
-
Emerging roles of JAK and TYK2 inhibitors
-
Combination biologic therapies in psoriatic arthritis
-
Modern treatment approaches for polymyalgia rheumatica
-
Management of eosinophilic granulomatosis with polyangiitis (EGPA)
-
Progress in hidradenitis suppurativa
Disease-Specific Management
-
Rheumatoid arthritis: disease management, flares, and multimorbidity
-
Psoriatic arthritis and psoriasis: prevention strategies and treatment optimization
-
Systemic lupus erythematosus: interferons and updated steroid protocols
-
Dermatomyositis: current insights and treatment considerations
-
Vasculitis: diagnosis, imaging, and management strategies
Diagnostics and Imaging
-
Imaging evaluation in spondyloarthritis
-
Imaging approaches in vasculitis
Clinical Strategy and Emerging Concepts
-
Application of artificial intelligence in rheumatoid arthritis care
-
Environmental factors in rheumatology
-
Long-term treatment monitoring and safety considerations
-
Management of complex and overlapping conditions
Interactive and Expert Discussions
-
Faculty panel discussions across key disease areas
-
Case-based insights and clinical decision-making strategies
Summary
RheumNow Live 2025 offers a structured and practical learning experience for clinicians aiming to enhance their expertise in rheumatology. By combining the latest research with real-world clinical applications, the course supports improved patient outcomes and informed decision-making in a rapidly evolving therapeutic landscape.